<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17083" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Achalasia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Momodu</surname>
            <given-names>Ifeanyi I.</given-names>
          </name>
          <aff>Campbell University School of OM</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Wallen</surname>
            <given-names>Jason M.</given-names>
          </name>
          <aff>Upstate Medical University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ifeanyi Momodu declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jason Wallen declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>31</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17083.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Achalasia is an esophageal smooth muscle motility disorder that occurs due to a failure of relaxation of the lower esophageal sphincter. This condition causes a functional obstruction at the gastroesophageal junction. This activity reviews the etiology, pathophysiology, and treatment of this condition, and highlights the need for collaboration amongst interprofessional team members to improve care coordination and in turn improve the diagnosis and treatment of this condition, leading to better outcomes for patients with achalasia.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Explain the pathophysiology of achalasia.</p></list-item><list-item><p>Outline what components go into the Eckardt symptom score and what each score means.</p></list-item><list-item><p>Identify the best first test for achalasia with the most sensitive test for achalasia.</p></list-item><list-item><p>Describe how collaboration amongst interprofessional team members to improve care coordination and minimize oversight, leading to earlier diagnosis and treatment and better outcomes for patients with achalasia.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17083&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17083">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17083.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Achalasia is not a common disorder in medicine. Most clinicians will not encounter a patient with this esophageal smooth muscle motility disorder, which occurs because the&#x000a0;lower esophageal sphincter&#x000a0;fails to relax<xref ref-type="bibr" rid="article-17083.r1">[1]</xref>. The esophagus also has a marked absence of peristalsis<xref ref-type="bibr" rid="article-17083.r2">[2]</xref>. In less than 50% of patients, the lower esophageal sphincter is hypertensive.<xref ref-type="bibr" rid="article-17083.r3">[3]</xref>&#x000a0;This&#x000a0;condition causes a functional obstruction at the gastroesophageal junction.</p>
      </sec>
      <sec id="article-17083.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Achalasia is thought to occur from the degeneration of the myenteric plexus and vagus nerve fibers of the lower esophageal sphincter.<xref ref-type="bibr" rid="article-17083.r2">[2]</xref><xref ref-type="bibr" rid="article-17083.r4">[4]</xref>&#x000a0;There is a loss of inhibitory neurons containing vasoactive intestinal peptide (VIP) and nitric oxide synthase at the esophageal myenteric&#x000a0;plexus, but in severe cases,&#x000a0;it also involves cholinergic neurons.<xref ref-type="bibr" rid="article-17083.r5">[5]</xref><xref ref-type="bibr" rid="article-17083.r6">[6]</xref>&#x000a0;The exact etiology of this degeneration is unclear though many theories have&#x000a0;been proposed. These theories include an autoimmune phenomenon, viral infection, and genetic predisposition.<xref ref-type="bibr" rid="article-17083.r7">[7]</xref><xref ref-type="bibr" rid="article-17083.r5">[5]</xref>&#x000a0;Most cases seen in the United States are primary idiopathic achalasia; however, secondary achalasia may be&#x000a0;seen&#x000a0;in&#x000a0;Chagas disease caused by Trypanosoma cruzi, esophageal infiltration by gastric&#x000a0;carcinoma, eosinophilic gastroenteritis, lymphoma,&#x000a0;certain&#x000a0;viral infections, and neurodegenerative&#x000a0;disorders.<xref ref-type="bibr" rid="article-17083.r5">[5]</xref></p>
      </sec>
      <sec id="article-17083.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Achalasia is very rare, occurring with an annual incidence&#x000a0;of roughly one per 100000 people and a prevalence of 10 per 100000.<xref ref-type="bibr" rid="article-17083.r8">[8]</xref>&#x000a0;It does not predominantly affect a particular age,&#x000a0;race, or gender. However,&#x000a0;a recent study showed increasing hospitalizations and associated costs for achalasia over the last 16 years in the United States with a disproportionate increase in patients under 65 years of age and racial minorities<xref ref-type="bibr" rid="article-17083.r8">[8]</xref>. For some unknown reason, the incidence of achalasia increases in individuals with spinal cord injury, but these cases typically relate to damage of the cervical and thoracic vertebrae.</p>
        <p>Altered esophageal motility similar to achalasia is also observed in individuals with anorexia nervosa. There are reports of achalasia after the use of endoscopic sclerotherapy for varices. The higher the number of sclerotherapy sessions, the greater the risk of achalasia. Most of these patients will show hypotensive peristalsis and defective lower esophageal sphincter function.</p>
        <p>Outside the United States, rates of achalasia vary from 0.1 to 1 per every 100000 people per year. Studies show that relapse rates are higher if the initial treatment was pneumatic dilatation. However, complications have been noted to be much higher in patients who underwent a Heller myotomy compared to those who underwent pneumatic dilatation.</p>
        <p>Achalasia occurs with equal frequency in both males and females. The disorder typically affects people between the second to the fifth decade of life with a&#x000a0;peak incidence&#x000a0;between the ages of 30 to 60 years.<xref ref-type="bibr" rid="article-17083.r8">[8]</xref>&#x000a0;Overall, less than 2% to 5% of cases occur in children less than age 16.</p>
      </sec>
      <sec id="article-17083.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The esophagus is the conduit of transport for food bolus from the mouth to the stomach, but it also prevents back reflux of the contents of the stomach. Coordinated peristaltic contractions&#x000a0;in the pharynx and esophagus pared with the relaxation of the upper and lower esophageal sphincters (LES)&#x000a0;achieve this transport.<xref ref-type="bibr" rid="article-17083.r5">[5]</xref>&#x000a0;Parasympathetic excitatory and inhibitory pathways innervate the smooth muscles of the lower esophageal sphincter. Excitatory neurotransmitters, such as substance P and acetylcholine, and inhibitory&#x000a0;neurotransmitters,&#x000a0;such as&#x000a0;vasoactive intestinal peptide (VIP) and nitric oxide (the most important&#x000a0;inhibitory&#x000a0;neurotransmitter&#x000a0;of the myenteric plexus), modulate lower esophageal sphincter&#x000a0;pressure&#x000a0;and&#x000a0;relaxation. Individuals with achalasia lack noncholinergic, nonadrenergic inhibitory ganglion cells, but the excitatory neurons remain unaffected.<xref ref-type="bibr" rid="article-17083.r9">[9]</xref> This lack of inhibitory ganglion cells results in an imbalance of inhibitory and excitatory neurotransmission.<xref ref-type="bibr" rid="article-17083.r7">[7]</xref><xref ref-type="bibr" rid="article-17083.r5">[5]</xref>&#x000a0;The result is a non-relaxed hypertensive esophageal sphincter.&#x000a0;</p>
        <p>Gradual neural degeneration directly results in excessive contractions of the lower esophageal sphincter and a loss of regulation.&#x000a0;This degeneration leads to&#x000a0;the functional obstruction, which then results in dilatation. This dilatation results in an irreversible aperistalsis and worsening obstructive symptoms. The reason that these changes occur is unclear.</p>
        <p>Some studies have investigated the association of achalasia with genetic polymorphisms of the three nitric oxide synthase isoforms and&#x000a0;specific Human Leukocyte Antigen (HLA) classes<xref ref-type="bibr" rid="article-17083.r9">[9]</xref>. One European study strongly supports the notion that achalasia may be an autoimmune disorder in which autoantibodies appear to interact with DNA, like in type 1 diabetes and lupus. A genetic association study of achalasia showed that an eight-residue&#x000a0;insertion at position 227-234 in the cytoplasmic tail of HLA-DQ&#x000df;1 confers the most potent known risk factor for achalasia while&#x000a0;two amino acid substitutions in the extracellular region of HLA-DQ<italic toggle="yes">a</italic>1 at position 41 and HLA-DQ&#x000df;1 at position 45 are independent risk factors for achalasia.<xref ref-type="bibr" rid="article-17083.r10">[10]</xref>&#x000a0;These investigators replicated this finding in another study, which&#x000a0;also showed that the insertion was more common in southern Europeans compared to northern Europeans&#x000a0;showing a geospatial north-south gradient among Europeans.<xref ref-type="bibr" rid="article-17083.r11">[11]</xref></p>
      </sec>
      <sec id="article-17083.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histopathological findings in advanced achalasia treated with total thoracic esophagectomy show a significant reduction in the number of myenteric ganglion cells and complete absence in some patients. Commonly seen inflammatory changes in the myenteric nerves comprise a mixture of lymphocytes, eosinophils (in all cases), and sometimes plasma and mast cells. Also,&#x000a0;the myenteric&#x000a0;nerves get focally or wholly replaced by collagen.<xref ref-type="bibr" rid="article-17083.r12">[12]</xref><xref ref-type="bibr" rid="article-17083.r7">[7]</xref></p>
        <p>Other extramyenteric&#x000a0;morphological features include submucosal periductal or glandular inflammation, muscular hypertrophy with secondary degeneration and fibrosis, diffuse squamous hyperplasia, lymphocytic mucosal esophagitis or inflammation of the lamina propria and submucosa with prominent germinal centers, infiltration of the muscularis externa&#x000a0;and propria by activated eosinophils.<xref ref-type="bibr" rid="article-17083.r7">[7]</xref><xref ref-type="bibr" rid="article-17083.r12">[12]</xref>&#x000a0;Activated eosinophils cause damage to tissues by producing cytotoxic eosinophil granule proteins such as eosinophil-derived&#x000a0;neurotoxin, eosinophilic cationic protein, and eosinophil major basic protein.<xref ref-type="bibr" rid="article-17083.r13">[13]</xref>&#x000a0;It is unclear if the inflammation observed is due to ongoing nerve damage or if it is a secondary phenomenon in response to achalasia.<xref ref-type="bibr" rid="article-17083.r7">[7]</xref><xref ref-type="bibr" rid="article-17083.r12">[12]</xref>&#x000a0;Another&#x000a0;study comparing histopathological changes in early versus advanced achalasia concluded that myenteric inflammation with an injury to and eventual loss of ganglion cells was the&#x000a0;initial pathological change leading to subsequent injury and fibrosis&#x000a0;of myenteric nerves.<xref ref-type="bibr" rid="article-17083.r14">[14]</xref></p>
      </sec>
      <sec id="article-17083.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The majority of patients with achalasia typically present with dysphagia, initially with solids than&#x000a0;to liquids though 70-97% of patients will have dysphagia to both solids and liquids at presentation.<xref ref-type="bibr" rid="article-17083.r15">[15]</xref>&#x000a0;Dysphagia and regurgitation are the most&#x000a0;common presenting&#x000a0;symptoms in achalasia.&#x000a0;More than half of patients will present with chest pain, but an improvement of esophageal emptying rarely alleviates the pain. As the disease progresses, patients may have symptoms of regurgitation with possible aspiration, nocturnal cough, heartburn, and weight loss from difficulty eating. Weight loss is often rapid because of the inability to swallow. Less common symptoms are hiccups or difficulty belching. Symptoms of dysphagia and regurgitation respond better to the treatment of underlying achalasia. Extra-esophageal symptoms commonly encountered are structural or functional pulmonary abnormalities likely from recurrent aspiration or tracheal compression from the dilated esophagus. A "bullfrog neck" appearance can occur from severe dilatation and distortion&#x000a0;of the cervical esophagus leading to tracheal obstruction and stridor. Specific gender distribution of symptoms is not typical though an Iranian study showed that chest pain was more common in women, while another study showed chest pain more common in patients less than 40. Variations in&#x000a0;symptom&#x000a0;distribution depend&#x000a0;on the population studied.<xref ref-type="bibr" rid="article-17083.r3">[3]</xref><xref ref-type="bibr" rid="article-17083.r5">[5]</xref><xref ref-type="bibr" rid="article-17083.r16">[16]</xref>&#x000a0;</p>
        <p>Physical examination may reveal an emaciated individual.</p>
        <p>A frequently used grading system for achalasia is the&#x000a0;Eckardt symptom score. It&#x000a0;is used in the evaluation of symptoms, stages, and efficacy of achalasia treatment. It assigns the four most common symptoms of the disease (weight loss, chest pain, dysphagia, and regurgitation) a score of 0-3 based on the severity of symptoms with a maximum total score of 12. A score of 0-1 corresponds to clinical stage 0, 2-3 to stage 1, 4-6 to stage 2, and greater than 6 to stage 3. Regarding prognosis, stages 0-1 indicate disease remission, while stages 2-3 represent a failure of treatment.<xref ref-type="bibr" rid="article-17083.r15">[15]</xref></p>
      </sec>
      <sec id="article-17083.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>When there is clinical suspicion for achalasia, diagnostic studies to confirm the disease must take place as symptoms do not reliably diagnose achalasia. It is also crucial to exclude benign and malignant causes of lower esophageal&#x000a0;obstruction<xref ref-type="bibr" rid="article-17083.r15">[15]</xref>.&#x000a0;&#x000a0;</p>
        <p>The best initial test to diagnose achalasia is a barium&#x000a0;esophagogram&#x000a0;(barium swallow). The classic finding on the barium swallow is the&#x000a0;smooth&#x000a0;tapering of the lower esophagus to a&#x000a0;&#x0201c;bird&#x02019;s beak" appearance, with&#x000a0;dilatation of the proximal esophagus and lack of peristalsis during fluoroscopy. Some cases reveal&#x000a0;an air-fluid level and&#x000a0;absence&#x000a0;of intra-gastric air while in advanced disease, a sigmoid-like&#x000a0;appearance&#x000a0;of the esophagus&#x000a0;may be visible.&#x000a0;A timed barium swallow is used&#x000a0;to access esophageal&#x000a0;emptying. This variant of the&#x000a0;classic barium&#x000a0;swallow&#x000a0;is&#x000a0;performed&#x000a0;by&#x000a0;having&#x000a0;the patient&#x000a0;drink 236 ml of barium in the upright position and taking&#x000a0;radiographs at one, two, and five minutes after the last swallow.&#x000a0;The height of the&#x000a0;barium&#x000a0;column after&#x000a0;five minutes, and the esophageal width&#x000a0;are&#x000a0;measured&#x000a0;pre and&#x000a0;post-treatment.<xref ref-type="bibr" rid="article-17083.r15">[15]</xref><xref ref-type="bibr" rid="article-17083.r16">[16]</xref>&#x000a0;</p>
        <p>Upper endoscopy (esophagogastroduodenoscopy -&#x000a0;EGD)&#x000a0;is recommended in all patients with suspected achalasia or dysphagia to exclude premalignant or malignant lesions involving the esophagus.<xref ref-type="bibr" rid="article-17083.r15">[15]</xref>&#x000a0;EGD has low accuracy&#x000a0;in the diagnosis of achalasia and may be normal in the early stages of the disease. Findings in advanced cases include rosette appearance&#x000a0;of the esophagogastric junction or an esophagus, which has become dilated, tortuous, and&#x000a0;atonic&#x000a0;often with retained food and saliva. The esophagus may be normal or show evidence of esophagitis due to chronic stasis. A firm resistance of the scope passing through the esophagogastric junction, especially in an older patient or one with a short duration of symptoms and significant weight loss, should raise the concern for pseudoachalasia, especially&#x000a0;malignancy. Other useful studies in cases of&#x000a0;pseudoachalasia&#x000a0;are CT scan, endoscopic ultrasound (to rule out submucosal lesions), and transabdominal ultrasound.<xref ref-type="bibr" rid="article-17083.r15">[15]</xref><xref ref-type="bibr" rid="article-17083.r16">[16]</xref></p>
        <p>Esophageal manometry is the most sensitive test for the diagnosis of achalasia and remains the gold standard.<xref ref-type="bibr" rid="article-17083.r17">[17]</xref>&#x000a0;Manometry will reveal incomplete lower esophageal sphincter&#x000a0;relaxation in response to swallowing, sometimes a lack of peristalsis in the lower esophagus, and an increase in pressure of the lower esophageal sphincter. The use of conventional manometry has mostly given way to high-resolution manometry (HRM), which also includes pressure topography plotting.<xref ref-type="bibr" rid="article-17083.r15">[15]</xref><xref ref-type="bibr" rid="article-17083.r16">[16]</xref><xref ref-type="bibr" rid="article-17083.r17">[17]</xref>&#x000a0;Using HRM, achalasia is classified by the&#x000a0;Chicago criteria (version 3.0) into three distinct categories, which have prognostic and treatment implications. Types1-3 all show incomplete lower esophageal sphincter relaxation. The esophageal body in type 1 shows aperistalsis and no esophageal pressurization, type 2 shows aperistalsis and&#x000a0;panesophageal pressurization in 20% or more of swallows while type 3 shows spastic (premature) contractions and distal contractility integral (DCI)&#x000a0;over 450 mmHG-s-cm in 20% or more of swallows. The integrated relaxation pressure in type 1 is 10mmHg, type 2 achalasia 15 mmHg, and type 3 achalasia 17 mmHg. Type 2 achalasia had the best positive response to treatment, and type 3 the least favorable response to treatment. The best initial treatment option for types 1 and 2 are conservative measures such as pneumatic dilatation and surgical myotomy, while type 3 achalasia appears to respond better to initial treatment with peroral endoscopic myomectomy (POEM).<xref ref-type="bibr" rid="article-17083.r15">[15]</xref><xref ref-type="bibr" rid="article-17083.r16">[16]</xref><xref ref-type="bibr" rid="article-17083.r17">[17]</xref>&#x000a0;&#x000a0;</p>
        <p>
<bold>Recommended Courses of Action</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Esophageal manometry to reveal incomplete lower esophageal sphincter&#x000a0;relaxation in response to swallowing, high resting lower esophageal sphincter&#x000a0;pressure, and the absence of esophageal peristalsis.</p>
          </list-item>
          <list-item>
            <p>Prolonged esophageal pH monitoring to rule out gastroesophageal reflux disease and determine if the treatment causes abnormal reflux</p>
          </list-item>
          <list-item>
            <p>Esophagogastroduodenoscopy&#x000a0;(EGD) to rule out any&#x000a0;cancer of the gastroesophageal junction or fundus</p>
          </list-item>
          <list-item>
            <p>Concomitant endoscopic ultrasonography if a tumor is suspected</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17083.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment is to ease the symptoms of achalasia by decreasing the outflow resistance caused by a non-relaxing and hypertensive lower esophageal sphincter. Current treatment modalities for primary idiopathic achalasia are nonsurgical or surgical. Nonsurgical options are pharmacotherapy, endoscopic botulinum toxin injection, or pneumatic dilatation. Surgical options are laparoscopic Heller myotomy (LHM) and peroral endoscopic myotomy (POEM).&#x000a0;</p>
        <p>Pharmacologic treatments include the administration of nitrates, calcium channel blockers, and phosphodiesterase-5 inhibitors to reduce the lower esophageal sphincter (LES) pressure. Calcium channel blockers inhibit the entry of calcium into the cells blocking smooth muscle contraction, leading to a decrease in LES pressure. Hypotension, pedal edema, headache, the rapid development of tolerance, and incomplete&#x000a0;symptom improvement are limiting factors to its use. Nitrates increase nitric oxide concentrations&#x000a0;in smooth&#x000a0;muscles, causing an&#x000a0;increase in cyclic adenosine monophosphate levels, which leads to smooth muscle relaxation. These&#x000a0;treatments are less effective, provide only short-term relief of symptoms, and are&#x000a0;primarily&#x000a0;reserved for patients who are waiting for or who refused more definitive therapy, such as pneumatic dilatation or surgery.<xref ref-type="bibr" rid="article-17083.r16">[16]</xref><xref ref-type="bibr" rid="article-17083.r17">[17]</xref></p>
        <p>Endoscopic&#x000a0;injection of botulinum toxin can be used in high-risk patients or those who relapse after myotomy. Botulinum&#x000a0;toxin, derived from Clostridium botulinum, is a potent biological neurotoxin known to block the release of acetylcholine at the level of the lower esophageal sphincter<xref ref-type="bibr" rid="article-17083.r16">[16]</xref>. This treatment is useful in patients who may not be candidates for surgery or dilatation or alternatively, as a bridge to more definitive therapy.&#x000a0;Limitations to botulinum&#x000a0;toxin injections are that the effect is short-lived (lasting about 6&#x000a0;to 12 months), patients often require multiple treatments that are expensive and may reduce the success of subsequent surgical myotomy.<xref ref-type="bibr" rid="article-17083.r18">[18]</xref><xref ref-type="bibr" rid="article-17083.r16">[16]</xref><xref ref-type="bibr" rid="article-17083.r17">[17]</xref></p>
        <p>Pneumatic dilatation of the esophagus via endoscopy is the&#x000a0;most cost-effective&#x000a0;non-surgical therapy for achalasia.<xref ref-type="bibr" rid="article-17083.r16">[16]</xref><xref ref-type="bibr" rid="article-17083.r17">[17]</xref>&#x000a0;Dilatation&#x000a0;of the esophagus is&#x000a0;achieved by&#x000a0;disrupting the circular fibers of the LES with air pressure using a graded dilator approach.&#x000a0;Symptoms improve in 50%-93% of patients; however, 30% of patients have symptom recurrence at five years<xref ref-type="bibr" rid="article-17083.r19">[19]</xref>. In some patients&#x000a0;with symptom recurrence, repeat pneumatic&#x000a0;dilatation&#x000a0;on-demand will provide&#x000a0;long-term remission. With on-demand repeat pneumatic dilatation, the long-term symptom relief is similar when compared with myotomy.<xref ref-type="bibr" rid="article-17083.r20">[20]</xref><xref ref-type="bibr" rid="article-17083.r16">[16]</xref><xref ref-type="bibr" rid="article-17083.r17">[17]</xref>&#x000a0;The failure rate with pneumatic dilation is higher with male gender, younger patients (with age less than 40), those with pulmonary complications, or failure of one or more previous pneumatic dilatations.<xref ref-type="bibr" rid="article-17083.r16">[16]</xref>&#x000a0;In young men, graded pneumatic dilation with a 3.0 cm balloon is more likely to fail compared to older men or women. Also, there is a higher risk of failure in this group of patients when starting with a 3.0 cm ballon.<xref ref-type="bibr" rid="article-17083.r21">[21]</xref>&#x000a0;The most common procedure-related complications are minor, but severe complications like esophageal perforation could occur and should&#x000a0;be treated accordingly.&#x000a0;Pneumatic dilatation is the first treatment option for a patient in whom surgery fails. If this also fails, the reason for the failure&#x000a0;must be identified&#x000a0;with imaging studies before&#x000a0;attempting a second operation.&#x000a0;</p>
        <p>The recommended step for reducing pressure across the lower esophageal sphincter&#x000a0;is surgical myotomy, which can be done laparoscopically.<xref ref-type="bibr" rid="article-17083.r22">[22]</xref> This procedure will cut the circular muscle fibers running across the lower esophageal sphincter, leading to relaxation. LHM can potentially cause uncontrolled gastroesophageal reflux, so it&#x000a0;typically pairs with an anti-reflux procedure such as Nissen, the posterior (Toupet), or the anterior (Dor) partial fundoplication. The anterior&#x000a0;fundoplication is the more common choice.&#x000a0;Laparoscopic Heller myotomy (LHM) with&#x000a0;partial fundoplication is the surgical&#x000a0;procedure of choice.<xref ref-type="bibr" rid="article-17083.r16">[16]</xref><xref ref-type="bibr" rid="article-17083.r17">[17]</xref>&#x000a0;The important thing is that the fundoplication is&#x000a0;partial, not complete, so as not to cause postoperative dysphagia, which is more severe with Nissen fundoplication.&#x000a0; The clinical success rate of LHM is high (76&#x000a0;to 100%) at 35 months, with a low mortality rate of 0.1%. Disease progression after five years subsequently reduces the success rate.&#x000a0;</p>
        <p>Peroral&#x000a0;endoscopic myotomy (POEM) is an effective minimally invasive alternative to laparoscopic Heller myotomy to treat achalasia at limited centers.<xref ref-type="bibr" rid="article-17083.r23">[23]</xref>&#x000a0;Dissection of the circular fibers of the LES is achieved endoscopically, leading to relaxation of the LES; however, the risk of gastroesophageal reflux is high because it does not include an&#x000a0;antireflux&#x000a0;procedure.&#x000a0;Esophagectomy is the last resort.</p>
      </sec>
      <sec id="article-17083.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>When a patient presents with dysphagia, the diagnosis of malignancy should always be in view.</p>
        <p>Other disorders in the differential include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Diffuse esophageal spasm</p>
          </list-item>
          <list-item>
            <p>Scleroderma</p>
          </list-item>
          <list-item>
            <p>Gastroesophageal reflux disease</p>
          </list-item>
          <list-item>
            <p>Stricture</p>
          </list-item>
          <list-item>
            <p>Schatzki ring</p>
          </list-item>
          <list-item>
            <p>Hiatal hernia</p>
          </list-item>
          <list-item>
            <p>Paraesophageal hernia</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17083.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The use of pneumatic dilatation and laparoscopic myotomy can produce&#x000a0;good results with symptom relief. Rates of esophageal perforation are rare after pneumatic dilatation, but relapses are frequent.&#x000a0;</p>
      </sec>
      <sec id="article-17083.s12" sec-type="Complications">
        <title>Complications</title>
        <list list-type="bullet">
          <list-item>
            <p>Esophageal perforation</p>
          </list-item>
          <list-item>
            <p>Recurrence</p>
          </list-item>
          <list-item>
            <p>Gastroesophageal reflux disease</p>
          </list-item>
          <list-item>
            <p>Bloating</p>
          </list-item>
          <list-item>
            <p>Potential cancer risk</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17083.s13" sec-type="Postoperative and Rehabilitation Care">
        <title>Postoperative and Rehabilitation Care</title>
        <p>All patients who undergo treatment for achalasia need long-term follow-up because all available treatments are palliative, making recurrences common. Additionally, some treatments for achalasia may also result in the development of reflux disease, which often requires treatment.</p>
      </sec>
      <sec id="article-17083.s14" sec-type="Consultations">
        <title>Consultations</title>
        <p>Consultation with a&#x000a0;thoracic surgeon and a gastroenterologist for management is essential.</p>
      </sec>
      <sec id="article-17083.s15" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Despite several years of research,&#x000a0;the precipitating factor in the development of&#x000a0;achalasia&#x000a0;is unknown. Theories have speculated that a viral infection sets off an autoimmune phenomenon&#x000a0;in a genetically susceptible host, but studies have failed to confirm this. Currently,&#x000a0;available treatment&#x000a0;options for achalasia do not focus on&#x000a0;halting disease progression but rather are directed at symptom relief such&#x000a0;as reducing dysphagia, chest pain, and regurgitation, preventing complications such as gastroesophageal reflux disease, weight loss, megaesophagus. Therefore, patients should receive counsel&#x000a0;that achalasia is a lifelong disease so that expectations about treatment outcomes are realistic. Patients also need to understand necessary lifestyle changes following myotomy, such as the need to eat small food boluses in an upright position, which allows&#x000a0;gravity to assist with food transit and never to&#x000a0;lay flat but&#x000a0;rather at 30 to 45 degrees&#x000a0;due to increased risk for aspiration.</p>
      </sec>
      <sec id="article-17083.s16" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Pneumatic dilatation and laparoscopic myotomy are&#x000a0;effective&#x000a0;treatments for managing achalasia. Surgery is preferred if an experienced surgeon is available.</p>
        <p>Do not use botulinum toxin and medications if performing a pneumatic dilatation or laparoscopic Heller myotomy.</p>
      </sec>
      <sec id="article-17083.s17" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Achalasia is a rare disorder of the esophagus with no cure. All currently available treatments remain palliative. The disorder is best managed with an interprofessional team to ensure good outcomes</p>
        <p>Coordination of care between the nutritionist, gastroenterologist, and thoracic surgeon by the primary care provider (nurse practitioner, physician assistant, or primary care physician) is essential. It is imperative that a diagnosis&#x000a0;is made&#x000a0;earlier by the primary care provider, especially as symptoms of reflux may be attributed&#x000a0;to GERD for years delaying diagnosis. Most patients are managed as an outpatient, but those with dehydration, severe malnutrition, or electrolyte abnormalities may need hospitalization for stabilization and hydration. Patients with significant weight loss need nutritional supplements&#x000a0;to prevent worsening malnutrition.</p>
        <p>The primary care clinicians, including the nurse practitioner, should encourage lifestyle changes. Maintaining healthy body weight and sleeping with the head of the bed elevated can help drain the esophagus with gravity. The dietitian should educate the patient on foods that should not be eaten and avoiding all solid foods at bedtime. The pharmacist should educate the patient on medications that can help with achalasia, as well as verifying dosing and checking for interactions, informing the treating clinician of any concerns that arise. In addition, the patient needs to be informed that while botulinum toxin does work in some patients, it is only a temporary treatment. The surgical nurse should educate the patient on pneumatic dilatation and myotomy, as well as assisting during the procedures and monitoring the patient.</p>
        <p>Even after successful treatment, life long follow-up of these patients is necessary as there is a small risk of malignancy. The interprofessional team should communicate with each other so that the patient receives the optimal standard of care treatment. The interprofessional team approach outlined above will drive patient outcomes positively. [Level 5]</p>
      </sec>
      <sec id="article-17083.s18">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17083&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17083">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/achalasia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=17083">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17083/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17083">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-17083.s19">
        <fig id="article-17083.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Beaklike narrowing of the distal esophagus with proximal distension, achalasia Contributed by Dawn Light, MD, MPH</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="achalasia2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-17083.s20">
        <fig id="article-17083.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Barium swallow showing achalasia Image courtesy S Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="achalasia1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-17083.s21">
        <fig id="article-17083.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Achalasia Manometry JC Petit, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/3.0/deed.en">Public Domain</ext-link>, via Wikimedia Commons</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Achalasia_EMS" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-17083.s22">
        <title>References</title>
        <ref id="article-17083.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Achem</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Crittenden</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kolts</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Burton</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Long-term clinical and manometric follow-up of patients with nonspecific esophageal motor disorders.</article-title>
            <source>Am J Gastroenterol</source>
            <year>1992</year>
            <month>Jul</month>
            <volume>87</volume>
            <issue>7</issue>
            <fpage>825</fpage>
            <page-range>825-30</page-range>
            <pub-id pub-id-type="pmid">1615935</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17083.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>CASSELLA</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>ELLIS</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>BROWN</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>FINE-STRUCTURE CHANGES IN ACHALASIA OF ESOPHAGUS. II. ESOPHAGEAL SMOOTH MUSCLE.</article-title>
            <source>Am J Pathol</source>
            <year>1965</year>
            <month>Mar</month>
            <volume>46</volume>
            <issue>3</issue>
            <fpage>467</fpage>
            <page-range>467-75</page-range>
            <pub-id pub-id-type="pmid">14266221</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17083.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fisichella</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Raz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Palazzo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Niponmick</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Patti</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Clinical, radiological, and manometric profile in 145 patients with untreated achalasia.</article-title>
            <source>World J Surg</source>
            <year>2008</year>
            <month>Sep</month>
            <volume>32</volume>
            <issue>9</issue>
            <fpage>1974</fpage>
            <page-range>1974-9</page-range>
            <pub-id pub-id-type="pmid">18575930</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17083.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>CASSELLA</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>ELLIS</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>BROWN</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>FINE-STRUCTURE CHANGES IN ACHALASIA OF THE ESOPHAGUS. I. VAGUS NERVES.</article-title>
            <source>Am J Pathol</source>
            <year>1965</year>
            <month>Feb</month>
            <volume>46</volume>
            <issue>2</issue>
            <fpage>279</fpage>
            <page-range>279-88</page-range>
            <pub-id pub-id-type="pmid">14256751</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17083.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Francis</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Katzka</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Achalasia: update on the disease and its treatment.</article-title>
            <source>Gastroenterology</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>139</volume>
            <issue>2</issue>
            <fpage>369</fpage>
            <page-range>369-74</page-range>
            <pub-id pub-id-type="pmid">20600038</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17083.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Misiewicz</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Waller</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Anthony</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Gummer</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Achalasia of the cardia: pharmacology and histopathology of isolated cardiac sphincteric muscle from patients with and without achalasia.</article-title>
            <source>Q J Med</source>
            <year>1969</year>
            <month>Jan</month>
            <volume>38</volume>
            <issue>149</issue>
            <fpage>17</fpage>
            <page-range>17-30</page-range>
            <pub-id pub-id-type="pmid">5765090</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17083.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raymond</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lach</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Shamji</surname>
                <given-names>FM</given-names>
              </name>
            </person-group>
            <article-title>Inflammatory aetiology of primary oesophageal achalasia: an immunohistochemical and ultrastructural study of Auerbach's plexus.</article-title>
            <source>Histopathology</source>
            <year>1999</year>
            <month>Nov</month>
            <volume>35</volume>
            <issue>5</issue>
            <fpage>445</fpage>
            <page-range>445-53</page-range>
            <pub-id pub-id-type="pmid">10583560</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17083.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wadhwa</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Thota</surname>
                <given-names>PN</given-names>
              </name>
              <name>
                <surname>Parikh</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Lopez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sanaka</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Changing Trends in Age, Gender, Racial Distribution and Inpatient Burden of Achalasia.</article-title>
            <source>Gastroenterology Res</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>70</fpage>
            <page-range>70-77</page-range>
            <pub-id pub-id-type="pmid">28496526</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17083.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ghoshal</surname>
                <given-names>UC</given-names>
              </name>
              <name>
                <surname>Misra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mittal</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Achalasia Is Associated With eNOS4a4a, iNOS22GA, and nNOS29TT Genotypes: A Case-control Study.</article-title>
            <source>J Neurogastroenterol Motil</source>
            <year>2015</year>
            <month>Jul</month>
            <day>30</day>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>380</fpage>
            <page-range>380-9</page-range>
            <pub-id pub-id-type="pmid">26088023</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17083.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gockel</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wouters</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Niebisch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gockel</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Hess</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ramonet</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zimmermann</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vigo</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Trynka</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>de Le&#x000f3;n</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>de la Serna</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Urcelay</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Franke</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Westra</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Drescher</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kneist</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Marquardt</surname>
                <given-names>JU</given-names>
              </name>
              <name>
                <surname>Galle</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Mattheisen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Annese</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Latiano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fumagalli</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Laghi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cuomo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sarnelli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eckardt</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Tack</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hoffmann</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Herms</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mangold</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Heilmann</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kiesslich</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>von Rahden</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Allescher</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Schulz</surname>
                <given-names>HG</given-names>
              </name>
              <name>
                <surname>Wijmenga</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Heneka</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hopfner</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>N&#x000f6;then</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Boeckxstaens</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>de Bakker</surname>
                <given-names>PI</given-names>
              </name>
              <name>
                <surname>Knapp</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schumacher</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Common variants in the HLA-DQ region confer susceptibility to idiopathic achalasia.</article-title>
            <source>Nat Genet</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>46</volume>
            <issue>8</issue>
            <fpage>901</fpage>
            <page-range>901-4</page-range>
            <pub-id pub-id-type="pmid">24997987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17083.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Becker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Haas</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Mokrowiecka</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wasielica-Berger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ateeb</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Bister</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Elbe</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kowalski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gawron-Kiszka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Majewski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mulak</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Janiak</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wouters</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Schw&#x000e4;mmle</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hess</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Veits</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Niebisch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Santiago</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>de Le&#x000f3;n</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>de la Serna</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Urcelay</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Annese</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Latiano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fumagalli</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Rosati</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Laghi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cuomo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lenze</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sarnelli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>von Rahden</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Wijmenga</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Czene</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>de Bakker</surname>
                <given-names>PI</given-names>
              </name>
              <name>
                <surname>Vieth</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>N&#x000f6;then</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Schulz</surname>
                <given-names>HG</given-names>
              </name>
              <name>
                <surname>Adrych</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>G&#x00105;siorowska</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Paradowski</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wallner</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Boeckxstaens</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Gockel</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Hartleb</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kostic</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dziurkowska-Marek</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lindblad</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nilsson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Knapp</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Thorell</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marek</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>D&#x00105;browski</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ma&#x00142;ecka-Panas</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Schumacher</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The HLA-DQ&#x003b2;1 insertion is a strong achalasia risk factor and displays a geospatial north-south gradient among Europeans.</article-title>
            <source>Eur J Hum Genet</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>24</volume>
            <issue>8</issue>
            <fpage>1228</fpage>
            <page-range>1228-31</page-range>
            <pub-id pub-id-type="pmid">26733285</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17083.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goldblum</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Whyte</surname>
                <given-names>RI</given-names>
              </name>
              <name>
                <surname>Orringer</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Appelman</surname>
                <given-names>HD</given-names>
              </name>
            </person-group>
            <article-title>Achalasia. A morphologic study of 42 resected specimens.</article-title>
            <source>Am J Surg Pathol</source>
            <year>1994</year>
            <month>Apr</month>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>327</fpage>
            <page-range>327-37</page-range>
            <pub-id pub-id-type="pmid">8141427</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17083.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jin</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Activated Eosinophils are Present in Esophageal Muscle in Patients with Achalasia of the Esophagus.</article-title>
            <source>Med Sci Monit</source>
            <year>2018</year>
            <month>Apr</month>
            <day>19</day>
            <volume>24</volume>
            <fpage>2377</fpage>
            <page-range>2377-2383</page-range>
            <pub-id pub-id-type="pmid">29672471</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17083.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goldblum</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Richter</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Histopathologic features in esophagomyotomy specimens from patients with achalasia.</article-title>
            <source>Gastroenterology</source>
            <year>1996</year>
            <month>Sep</month>
            <volume>111</volume>
            <issue>3</issue>
            <fpage>648</fpage>
            <page-range>648-54</page-range>
            <pub-id pub-id-type="pmid">8780569</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17083.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laurino-Neto</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Herbella</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Schlottmann</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Patti</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>EVALUATION OF ESOPHAGEAL ACHALASIA: FROM SYMPTOMS TO THE CHICAGO CLASSIFICATION.</article-title>
            <source>Arq Bras Cir Dig</source>
            <year>2018</year>
            <volume>31</volume>
            <issue>2</issue>
            <fpage>e1376</fpage>
            <pub-id pub-id-type="pmid">29972404</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17083.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eckardt</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Eckardt</surname>
                <given-names>VF</given-names>
              </name>
            </person-group>
            <article-title>Current clinical approach to achalasia.</article-title>
            <source>World J Gastroenterol</source>
            <year>2009</year>
            <month>Aug</month>
            <day>28</day>
            <volume>15</volume>
            <issue>32</issue>
            <fpage>3969</fpage>
            <page-range>3969-75</page-range>
            <pub-id pub-id-type="pmid">19705490</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17083.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Torresan</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ioannou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Azzaroli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bazzoli</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Treatment of achalasia in the era of high-resolution manometry.</article-title>
            <source>Ann Gastroenterol</source>
            <year>2015</year>
            <season>Jul-Sep</season>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>301</fpage>
            <page-range>301-308</page-range>
            <pub-id pub-id-type="pmid">26130022</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17083.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zaninotto</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Annese</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Costantini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Del Genio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Costantino</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Epifani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gatto</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>D'onofrio</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Benini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Contini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Molena</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Battaglia</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tardio</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Andriulli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ancona</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Randomized controlled trial of botulinum toxin versus laparoscopic heller myotomy for esophageal achalasia.</article-title>
            <source>Ann Surg</source>
            <year>2004</year>
            <month>Mar</month>
            <volume>239</volume>
            <issue>3</issue>
            <fpage>364</fpage>
            <page-range>364-70</page-range>
            <pub-id pub-id-type="pmid">15075653</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17083.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Csendes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Braghetto</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Henr&#x000ed;quez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cort&#x000e9;s</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Late results of a prospective randomised study comparing forceful dilatation and oesophagomyotomy in patients with achalasia.</article-title>
            <source>Gut</source>
            <year>1989</year>
            <month>Mar</month>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>299</fpage>
            <page-range>299-304</page-range>
            <pub-id pub-id-type="pmid">2651226</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17083.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boeckxstaens</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Annese</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>des Varannes</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Chaussade</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Costantini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cuttitta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Elizalde</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Fumagalli</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Gaudric</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rohof</surname>
                <given-names>WO</given-names>
              </name>
              <name>
                <surname>Smout</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Tack</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zwinderman</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Zaninotto</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Busch</surname>
                <given-names>OR</given-names>
              </name>
              <collab>European Achalasia Trial Investigators</collab>
            </person-group>
            <article-title>Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia.</article-title>
            <source>N Engl J Med</source>
            <year>2011</year>
            <month>May</month>
            <day>12</day>
            <volume>364</volume>
            <issue>19</issue>
            <fpage>1807</fpage>
            <page-range>1807-16</page-range>
            <pub-id pub-id-type="pmid">21561346</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17083.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Farhoomand</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Connor</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Richter</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Achkar</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Vaezi</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>Predictors of outcome of pneumatic dilation in achalasia.</article-title>
            <source>Clin Gastroenterol Hepatol</source>
            <year>2004</year>
            <month>May</month>
            <volume>2</volume>
            <issue>5</issue>
            <fpage>389</fpage>
            <page-range>389-94</page-range>
            <pub-id pub-id-type="pmid">15118976</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17083.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonavina</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nosadini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bardini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Baessato</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Peracchia</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Primary treatment of esophageal achalasia. Long-term results of myotomy and Dor fundoplication.</article-title>
            <source>Arch Surg</source>
            <year>1992</year>
            <month>Feb</month>
            <volume>127</volume>
            <issue>2</issue>
            <fpage>222</fpage>
            <page-range>222-6; discussion 227</page-range>
            <pub-id pub-id-type="pmid">1540102</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17083.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>von Renteln</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Inoue</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Minami</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Werner</surname>
                <given-names>YB</given-names>
              </name>
              <name>
                <surname>Pace</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kersten</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Much</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Schachschal</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mann</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Keller</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fuchs</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>R&#x000f6;sch</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Peroral endoscopic myotomy for the treatment of achalasia: a prospective single center study.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>107</volume>
            <issue>3</issue>
            <fpage>411</fpage>
            <page-range>411-7</page-range>
            <pub-id pub-id-type="pmid">22068665</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
